Nefiracetam

• Dry-fill capsules
• 100 mg capsules (120 count / 12 g total)
• 450 mg capsules (60 count / 27 g total)
• 20 grams powder

• GABA receptor modulation: May enhance activity at GABA(A) receptors, supporting a calmer, anti anxiety effect without heavy sedation.
• Cholinergic support: May increase acetylcholine signaling, which is tied to learning and memory.
• NMDA receptor activity: May influence NMDA receptors involved in synaptic plasticity and learning, with effects linked to calcium signaling in neurons.
• Neuroprotective signaling: May reduce neuroinflammation and oxidative stress markers, supporting long term brain health models.

Nefiracetam is commonly studied for

• Memory support: Discussed for improving short term and long term memory by supporting synaptic plasticity and acetylcholine activity.
• Anxiety reduction: Commonly discussed for promoting a calmer state, which may be useful in stressful or social situations.
• Mood support: May influence dopamine and serotonin receptor sensitivity, which is why some people associate it with mood uplift.
• Neuroprotection: Discussed in cognitive decline contexts due to protective signaling in brain models.
• Learning capacity: Often used with the goal of improving learning efficiency and cognitive performance.

Nefiracetam is generally described as well tolerated in research settings, but potential side effects reported include

• Headaches (often linked to increased acetylcholine activity; some people find choline support helps)
• Nausea or gastrointestinal discomfort (more common when starting)
• Insomnia (especially if taken later in the day)
• Overstimulation (more likely at higher amounts)
• Potential liver stress (rare, discussed mainly with high dose or long term use)
• Kidney stress signals in animal data (reported in dog studies)

Researchers often adjust cholinergic support carefully to avoid overstimulation when combining Nefiracetam with other acetylcholine-enhancing compounds.